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William Berthon a, Ildikó Pap f, Ildikó Szikossy f, Frank Maixner g, Albert Zink g, 
Csaba Vágvölgyi b, Helen D. Donoghue h, David E. Minnikin i, András Szekeres b, György Pálfi a 
a Department of Biological Anthropology, Faculty of Science and Informatics, University of Szeged, Hungary. Postal address: Közép fasor 52, H-6726, Szeged, Hungary 
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A B S T R A C T   
Tuberculosis (TB) was a large burden of infections that peaked during the 19th century in Europe. Mummies 
from the 18th century CE, discovered in the crypt of a church at Vác, Hungary, had high TB prevalence, as 
revealed by amplification of key fragments of TB DNA and genome-wide TB analysis. Complementary methods 
are needed to confirm these diagnoses and one approach uses the identification of specific lipid biomarkers, such 
as TB mycocerosic acids (MCs). Previously, MC derivatives were profiled by specialised gas chromatography- 
mass spectrometry (GC-MS), so an alternative more direct approach has been developed. Underivatized MCs 
are extracted and analysed by high-performance liquid chromatography linked to a mass spectrometer, in heated 
electrospray ionisation mode (HPLC-HESI-MS). The method was validated using representatives of the Myco-
bacterium tuberculosis complex and other mycobacteria and tested on six Vác mummy cases, previously consid-
ered positive for TB infection. Analysing both rib and soft tissue samples, four out of six cases gave profiles of 
main C32 and major C29 and C39 mycocerosates correlating well with those of M. tuberculosis. Multidisciplinary 
methods are needed in the diagnosis of ancient tuberculosis; this new protocol accesses important confirmatory 
evidence, as demonstrated by the confirmation of TB in the Vác mummies.   
1. Introduction 
Tuberculosis (TB) has been present in the history of mankind for at 
least ten millennia [1], but the traces of its infectious agent could be 
detected from animal bone remains of a far earlier era [2]. Although the 
prevalence of the disease peaked between 1896 and 1905 in Hungary 
Abbreviations: mycocerosic acid, (MC); mycolic acid, (MS); Mycobacterial Outer Membrane, (MOM); phthiocerol, (PDIM); phenolic glycolipid, (PGL); poly-
tetrafluoroethylene, (PTFE); isopropanol, (IPA); acetonitrile, (MeCN); selected ion monitoring, (SIM); atmospheric pressure chemical ionisation, (APCI); (heated) 
electrospray ionisation, ((H)ESI). 
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E-mail addresses: varadi.orsolya.90@gmail.com (O.A. Váradi), rakkdavid@gmail.com (D. Rakk), olga.spekker@gmail.com (O. Spekker), terhesga@gmail.com 
(G. Terhes), zsoldiedit25@gmail.com (E. Urbán), william.berthon@gmail.com (W. Berthon), papildi@hotmail.com (I. Pap), szikossy@gmail.com (I. Szikossy), 
frank.maixner@eurac.edu (F. Maixner), albert.zink@eurac.edu (A. Zink), mucor1959@gmail.com (C. Vágvölgyi), h.donoghue@ucl.ac.uk (H.D. Donoghue), d.e. 
minnikin@bham.ac.uk (D.E. Minnikin), andras.j.szekeres@gmail.com (A. Szekeres), gypalfi@hotmail.com (G. Pálfi).  
Contents lists available at ScienceDirect 
Tuberculosis 
journal homepage: http://www.elsevier.com/locate/tube 
https://doi.org/10.1016/j.tube.2020.102037 
Received 5 October 2020; Received in revised form 25 November 2020; Accepted 29 November 2020   
Tuberculosis 126 (2021) 102037
2
[3], tuberculosis had been proven to be present in the Carpathian Basin 
at least since the Neolithic period [4]. On the grounds of the remarkable 
importance of these infections around the world, TB remains a priori-
tized research topic. This includes not only the study of recent cases but 
also the investigation of archaeological samples, which could help in the 
better understanding of the disease and its evolution [5–7]. For this 
purpose, paleopathologists usually use well-documented collections of 
skeletons and mummies from the pre-antibiotic era to study the in-
fections themselves, as well as to identify new TB-related macro-
morphological diagnostic criteria [8–12]. The Vác mummy collection 
can be considered as an excellent example of the above-mentioned 
collections. Among other advantages of this collection, the main 
reason for selecting them in our research is that several results of 
TB-related investigations and individual data are available regarding 
this group. As these mummies are dated to the modern age, they also 
represent an excellent link between recent and archaeological samples 
[13–18]. 
The examined mummy collection was discovered in a long-forgotten 
crypt during the renovation of the Dominican Church of Vác in 
1994–1995 [13] (Fig. 1). The mummies are curated in the Department of 
Anthropology, Hungarian Natural History Museum, Budapest. The 
chamber had been used as a burial site for middle-class families and 
ecclesiastical individuals from 1731 until 1838. On the site, the remains 
of 265 individuals were found and, fortunately, most of them were 
naturally mummified. During the years, the remains have undergone 
several investigations with a broad variety of techniques, such as 
morphological analysis, dermatological examination, X-ray imaging, 3D 
reconstruction, and aDNA examination [14–20]. Considering the high 
prevalence of TB in this era and the suspicion of TB-infected cases based 
on macromorphological observations, an extended screening was car-
ried out searching for DNA traits of the infectious agent. Fletcher and her 
colleagues [14] examined over 350 samples covering 168 individuals. 
The samples were taken from the lungs, pleura, abdomen, ribs, hair, 
teeth, and clothing. They found that 55% of the individuals proved to be 
infected with Mycobacterium tuberculosis complex (MTBC), based on the 
PCR amplification of IS6110, 19-kDa antigen and MPB70 antigen genes, 
as well as dnaA-dnaN spacer regions. Moreover, they monitored the si-
lent point mutations of the gyrA 95 and katG 463 genes. In a later study, 
metagenomics analysis was also carried out on a lung tissue sample 
taken from Terézia Hausmann, in which signs of a mixed infection were 
recorded, with the presence of two different M. tuberculosis strains [18]. 
In 2015, samples were taken from 26 of the Vác mummies, whose 
extracted MTBC DNA were analysed phylogenetically based on 
sequencing results [15]. From eight individuals, 14 different 
M. tuberculosis genome sequences have been successfully determined. 
Furthermore, each infectious agent belongs to the M. tuberculosis Line-
age 4, which is represented in a high occurrence globally even today [15, 
21]. 
Complementing the aDNA-based detections, the utilization of lipid 
biomarker-based diagnostic techniques on archaeological samples has 
been in practise since the end of the ‘90s [22,23]. These methods benefit 
from the lipid-rich cell wall, characteristic of mycobacteria. Two cell 
wall constituent groups, the mycolic acid (MA), the mycocerosic acid 
(MC) components and, also the C27 mycolipenic acid, are commonly 
used for this purpose [24–26]. All of these lipids can be found in the 
Mycobacterial Outer Membrane (MOM) [27]. While MAs are mainly 
covalently bound to the mycoloylarabinogalactan-peptidoglycan mac-
romolecules, MCs are long-chain multimethyl-branched-chain fatty 
acids (Fig. 2) that are components of phthiocerol dimycocerosate 
(PDIM) waxes and glycosyl phenolphthiocerol dimycocerosates, the 
so-called “phenolic glycolipids” (PGLs) [25–28]. MCs can be found only 
in the strains of M. tuberculosis, Mycobacterium bovis, Mycobacterium 
gastri, Mycobacterium haemophilum, Mycobacterium kansasii, Mycobacte-
rium leprae, Mycobacterium marinum and Mycobacterium ulcerans [25, 
29–33]. 
The development of lipid biomarker diagnosis of ancient mycobac-
terial disease has been reviewed in detail [26], but it is summarised as 
follows. Initially, methylanthryl MA derivatives were profiled by fluo-
rescence high performance liquid chromatography (HPLC) [22,23]. The 
very large C70 – C90 MAs were distinguished, according to size, from all 
mammalian fatty acids by reverse phase HPLC and the total MAs were 
collected. The individual α-, methoxy- and keto MA types were resolved 
Fig. 1. Source of the Vác mummy samples. A, The late Terézia Damiani (Body 79, Inv. No: 2009.19.79.); B, The late Terézia Hausmann (Body 68, Inv. No: 
2009.19.68.); C, Dominican Church of Vác. Photo: András Thumbasz; D, Location of Vác. 
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by normal phase HPLC and the collected fractions analysed by reverse 
phase HPLC to provide diagnostic profiles [22,23]. The relative insta-
bility of methylanthryl derivatives led to the more robust fluorescence 
HPLC use of pyrenebutyrates of pentafluorobenzyl MA esters [24,26, 
34]. Direct electrospray ionisation mass spectrometry (ESI-MS) detec-
tion of M. tuberculosis free MAs has been successful in a single example 
[35]. The smaller C27 – C33 mycocerosic acids (MCs) (Fig. 2) are 
amenable to gas chromatographic (GC) profiling [29–33]. Highly sen-
sitive negative ion-chemical ionisation gas chromatography mass spec-
trometry (NI-CI GC-MS) of pentafluorobenzyl esters was developed for 
their detection in archaeological material [25,26] and applied to a range 
of specimens [1,2,4,36,37]. 
Since the lipid biomarker-based diagnostic methods, including 
mycocerosic acid profiling, were proven to be efficient and reliable [1,2, 
22–27,34–37], we chose to optimise a similar method. As a GC-MS 
method was already well characterized in the literature [25,33], in 
our study, a novel HPLC-HESI-MS detection based method was devel-
oped for MCs and tested on a sample set selected from the published 
positive cases of the Vác mummy collection, previously examined by 
aDNA techniques. 
2. Materials 
For the method optimisation, two reference strains, M. tuberculosis 
H37Rv (NR-49098) and M. bovis (NR-31210), were used. The reference 
strains were acquired from the American Type Culture Collection 
(ATCC), provided by BEI Resources (Manassas, Virginia, USA). For the 
method testing, we used five M. tuberculosis complex strains (laboratory 
IDs of the isolated strains MTBC-1/2015; MTBC-254/2000; MTBC- 
3910/2014; MTBC-242/2000; and MTBC-1/8508/2014), isolated from 
patients diagnosed with pulmonary tuberculosis. Also, eight different 
NTM (Nontuberculous Mycobacteria) species, namely M. kansasii 1959/ 
2018, Mycobacterium chelonae 16/2018, Mycobacterium gordonae 389/ 
2018, Mycobacterium intracellulare 7802/2017, Mycobacterium abscessus 
ssp. abscessus 180/2018, Mycobacterium avium 16229/2018, 
Mycobacterium fortuitum complex 3/2018 and Mycobacterium chimaera 
619/2018 from various clinical specimens were studied. The isolation of 
these strains from clinical specimens was carried out in two laboratories, 
namely the Institute of Clinical Microbiology, University of Szeged, 
Szeged, Hungary and the National Korányi Institute of TB and Pulmo-
nology, Budapest, Hungary, according to the national recommendations 
[38]. The identification of the isolated strains was carried out using 
commercially available tests following the instructions of the manu-
facturer, (MALDI-TOF mass spectrometry, Bruker/Hain Lifescience) and 
sequencing ((Cepheid, Becton Dickinson) 16S rDNA, rpoB and hsp 65 
sequence analysis). Culture was carried out using Löwenstein-Jensen 
medium (L-asparagine, monopotassium phosphate, magnesium sulfate, 
magnesium citrate, soluble potato starch, malachite green, whole eggs, 
glycerol and demineralized water) for 1–3 weeks, incubating at 37 ◦C. In 
case of adequate growth and pure culture, the strains were inoculated 
into fresh media and cultured for a further 1–3 weeks at 37 ◦C. The cells 
were inactivated by heating for 4 h in physiological saline solution and 
stored at − 20 ◦C, after freeze-drying. For the method optimisation, 20 
mg of freeze-dried bacterial material was used. 
The examined bone and soft tissue samples were from six in-
dividuals, selected on the base of previous positive results gained by 
aDNA examination [14,15] (Table 1). The sampled adult individuals 
were four females and two males. The analysed mummy samples (both 
bone and soft tissue samples) were taken from the chest region of the 
examined individuals. The samples were removed by sanitized tweezers 
and stored in tightly closed bags separated well from each other at room 
temperature. The ribs have been powdered, while the soft tissues were 
processed in the clean laboratory of the Institute for Mummy Studies, 
EURAC Research, Bolzano, Italy. 
3. Methods 
3.1. Lipid extraction and purification 
The lipid extraction was carried out according to a previously 
Fig. 2. Structures of mycocerosic acids. The mass spectral m/z values correspond to carboxylate anions (M – H+).  
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published method [24] with minor modifications. The samples were 
heated at 100 ◦C overnight with 20% KOH in MeOH (2 ml; m/V) and 
toluene (1 ml) in PTFE capped glass tubes; for bacterial samples, 20 mg 
was used. The sample amounts from each examined individual are 
shown in Table 1. The tubes were cooled and 10% HCl (1 ml) was added 
in an ice bath; the pH was finally set to 1 with the addition of 37% HCl 
solution. Thereafter, toluene was added (1 ml) to the samples and after 
1 min of vortexing, they were centrifuged at 1200 rpm for 15 min. The 
organic layer was transferred into a new glass tube, while the bottom 
layer was re-extracted twice with the same method with the further 
addition of toluene and one more time with hexanes (1 ml). The 
collected and combined organic phases were evaporated to dryness in 
vacuum with a Savant SC250EXP SpeedVac concentrator (Thermo Sci-
entific, Waltham, Massachusetts, USA) and dissolved in 1000 μl and 200 
μl isopropanol (IPA):heptane:acetonitrile (MeCN) (4:1:5) in the case of 
bacterial and mummy samples, respectively. The sample solutions were 
filtered by PTFE syringe filters (pore size: 2.0 μm; diameter: 13 mm). 
3.2. Mycocerosic acid separation and detection by mass spectrometry 
The measurements were carried out on a Dionex Ultimate 3000 
UHPLC system (Thermo Scientific, Waltham, Massachusetts, USA), 
which was coupled with a Q-Exactive Plus (Thermo Scientific, Waltham, 
Massachusetts, USA) mass spectrometer (MS). For the separation, a 
Gemini – NX C18 (3 μm, 110A, 50 mm × 2 mm) column (Phenomenex, 
Torrance, California, USA) was used at 30 ◦C. The eluent A was MeCN, 
containing 0.1% acetic acid (AcOH), while eluent B consisted of IPA: 
heptane (8:2), also supplemented with 0.1% AcOH. The flow rate was 
200 μl/min and the applied gradient elution was the following: at 0 min 
10% B, 5 min 15% B, 15 min 70% B, 16 min 90% B, 18 min 90% B, 18.5 
min 20% B, 19.5 min 20% B, 20 min 90% B, 23 min 90% B, 24 min 10% 
B and 28 min 10% B. The injection volume was 10 μl. The injection 
needle was thoroughly washed, before and after injection, with 150 μl 
IPA:heptane (8:2). Solvent blank injections were made between each 
sample investigation. 
In the case of MS settings, certain parameters were optimised, while 
the sheath gas flow and the auxiliary gas rates were constant at 35 l/min 
and 10 l/min, respectively. The structures of the investigated MCs are 
shown in Fig. 2. The MCs were monitored in negative Selected Ion 
Monitoring (SIM) mode: 409.40510 (C27, C27H53O2), 437.43640 (C29, 
C29H57O2), 451.45205 (C30, C30H59O2), 479.48335 (C32, C32H63O2) 
and 493.49900 (C33, C33H65O2), with 0.4 m/z isolation window. The 
area values of the MC peaks were calculated with TraceFinder 4.0 
General Quan Software (Thermo Scientific, Waltham, Massachusetts, 
USA). The maximum mass deviation from the calculated [M − H]- ion 
mass was 5 ppm for peak identification. During the evaluation, the 
detected MC peaks have been normalised to the peak with the highest 
area value. 
4. Results and discussion 
4.1. Optimisation of the HPLC-MS protocols for the analysis of 
mycocerosic acids 
For the method optimisation, the MC mixture extracted from 
M. tuberculosis H37Rv was used. In the case of HPLC-MS based lipid 
analysis, the two most commonly used ion sources are the atmospheric 
pressure chemical ionisation (APCI) and (heated) electrospray ionisa-
tion modes ((H)ESI) [39–43]. APCI is suitable to examine several kinds 
of lipids, providing relatively simple mass spectra, but it can certainly 
lead to the degradation of labile lipids [39,40]. ESI compared to APCI 
provides a softer ionisation, and it is also minimising the undesired 
in-source fragmentation, thus the ions can be transferred into the gas 
phase, while preserved to be intact [44–47] as well as a well-established 
ESI-MS method can provide an extremely high-sensitivity and good 
reproducibility [46,48]. Therefore, regarding the advantages of ESI ion 
source, ESI-MS became a popular tool in lipid research [40,45,47–49]. 
To find out whether APCI or ESI is more efficient with our target lipids, 
these two widely used ion sources were compared to each other. To 
enable the assessment of the effect of the various parameters, a reference 
profile of the MCs of M. tuberculosis, observed during the application of 
HESI ion source, is included in Fig. 3. 
First, the MS parameters were tuned with both ion sources. The 
optimisation was carried out in flow injection analysis (5 μl) with 50% of 
both eluent A and B at 200 μl/min flow rate. Initially, the temperature of 
both the capillary and the auxiliary gas of the HESI ion source were 
tuned at 4 kV spray voltage and a 60 V of S-lens voltage, as a basic 
setting. It was found that increasing the capillary temperature from 
300 ◦C to 350 ◦C increased the intensity approximately to 150% 
(Figs. 4.1 and 4.2). As the auxiliary gas temperature is also affecting the 
ionisation, the effect caused by its change was also tested. The increase 
of its temperature to 350 ◦C had caused a 120% increase in the inte-
grated area values (Figs. 4.1 and 4.3). With the combined increase of the 
capillary and auxiliary gas temperature, doubled intensity of the 
monitored peaks was gained (Figs. 4.1 and 4.4). As further optimisation, 
the possible effects of using APCI as ion source had been tested, but even 
with a high increase of the capillary temperature from 250 ◦C first to 
350 ◦C (Figs. 4.5 and 4.6) and then up to 400 ◦C did not give enough rise 
to the intensity (Figs. 4.6 and 4.7), which would have made further 
optimisation steps on this way promising. After finding that the usage of 
HESI ion source is more effective, the S-lens voltage, as an important 
factor in signal intensification, was also optimised. Its increase from 60 
V to 70 V caused approximately 1.3 times increase in the intensity 
(Figs. 4.4 and 4.8). Further increase did not affect the intensity consid-
erably (Figs. 4.8 and 4.9). Finally, the optimal settings of the MS were 
the following: the capillary and the auxiliary gas was heated to 350 ◦C, 
the spray voltage was set to 4 kV, while the S-lens voltage was 70 V 
(Fig. 4.8). 
During the chromatographic run, M. tuberculosis MCs were eluting 
between 5.8 and 10.98 min (Fig. 3 A). The first eluting component was 
the C27 mycocerosic acid (Rt: 5.96), the second was the C29 (Rt: 8.15), 
followed by C30 (Rt: 8.73), C32 (Rt: 10.61) and C33 (Rt: 10.98), 
respectively. After the retention times had been observed, the divert 
Table 1 
Details of the examined individual mummies and presence or absence of mycocerosic acid profiles typical of M. tuberculosis.  
Name Body number Inventory number Age at death Sample weight (mg) MTB mycocerosic acid profile 
Bone sample Soft tissue sample Bone sample Soft tissue sample 
Terézia Hausmann #68 2009.19.68. 28 400 284 + +
Anna Schneller #78 2009.19.78. 48 699 459 + +
Erzsébet Virágh #80 2009.19.80. 37 500 193 + +
László Beniczky #121 2009.19.121. ~38 500 482 + +
Gáspár Steitel #25 2009.19.25. 58 500 227 – – 
Terézia Damiani #79 2009.19.79. 37 519 257 – –  
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valve was set to switch to be open in the direction of the MS only from 5 
to 15 min to avoid the contamination of the instrument. In the case of 
M. tuberculosis H37Rv strain, the C32 (100%) MC is the most abundant, 
followed by C29 (57%) and C30 (50%) MCs, with C27 (9%) and C33 
(8%) as minor components (Fig. 3A). To check the repeatability of the 
whole method, including sample preparation and detection, the relative 
standard deviation (RSD) values were calculated for three individually 
prepared parallel samples. The highest RSD was determined for the C27 
MC (28%), while C29 and C33 MCs showed 12% and 5% RSD, 
respectively; the lowest RSD values were observed for the C30 (3%) and 
C32 MCs (0%). 
The mycobacterial mycocerosate HPLC profiles, recorded here, 
correspond well with those recorded previously by NI-CI GC-MS of 
pentafluorobenzyl esters [2,25,26]. In the GC-MS method, however, C29 
and C30 MCs co-chromatograph, the additional methyl branch in the 
C30 component (Fig. 2) providing enhanced volatility. In this HPLC 
study, the additional carbon in the C30 MC ensures that it is retained 
longer by the reverse phase column media (Fig. 3), subtle structural 
differences being less influential in the liquid phase. A similar rela-
tionship is seen for the C32 and C33 MCs (Fig. 3). The current 
non-aqueous alkaline hydrolysis procedure is efficient in releasing MCs 
from the very hydrophobic parent phthiocerol dimycocerosate waxes [2, 
25]. However, this non-aqueous environment promotes racemisation of 
the chiral centre at carbon-2 of MCs (Fig. 2), yielding diastereoisomers. 
The high-resolution capillary columns employed in the NI-CI GC-MS 
procedure can resolve these diastereoisomers to give highly diagnostic 
double peaks [2,26]. Such resolution is not achieved by the 
reverse-phase HPLC used in this study. 
4.2. Profiles of mycocerosic acids from standard mycobacteria 
After the method optimisation, our aim was to build up an MC profile 
library for later comparisons. For establishing the MC profiles, three 
individually prepared parallel samples had been used in the case of 
every strain. First, the profile of M. bovis (ATCC, NR-31210) had been 
established. The C29 MC has been presented in the highest ratio (0% 
RSD). It was followed by the C27 and C32 MCs with 30 and 28% (10 and 
20% RSD, respectively). The least presented MCs were C30 and C33 
MCs, and their area value was 21% and 2% of the highest peak (14 and 
13% RSD, respectively) (Fig. 3B). 
During the examinations of NTM isolates, in the case of M. kansasii, 
the C30 MC was recorded in the highest ratio (0% RSD). It was followed 
by the C29 (38%, 14% RSD) and C32 MC (30%, 7% RSD), while the C27 
and C33 MCs were presented in 16% (2% RSD) and 2% (14% RSD), 
respectively (Fig. 3C). Among the rest of the NTM species (Supple-
mentary Figure 1), a peak co-chromatographing with C27 MC was seen 
in the M. avium strain, but the other monitored MCs were not detectable; 
the true identity of this component remains to be established. The 
remainder of the examined NTM species did not show any traces of the 
monitored MCs (Supplementary Figure 1 and Supplementary Figure 2). 
These results correlate well with previously published data, which point 
to the fact that MCs can be found only in the following species: 
M. tuberculosis, M. bovis, M. gastri, M. haemophilum, M. kansasii, M. leprae, 
M. marinum, and M. ulcerans [25,29–33]. An extended study presenting 
a THM-GC-MS based method for the differentiation of M. tuberculosis 
from NTM species came to a similar result [50]. In this study, the applied 
MC biomarkers have not been detected in the following NTM species: 
M. avium, M. chelonae, M. fortuitum, M. gordonae, M. abscessus, M. 
chimaera and M. intracellulare (Supplementary Figure 1 and Supple-
mentary Figure 2). The MC profile from M. kansasii (Fig. 3C) includes 
significant proportions of C32 MCs, which correlates with its perceived 
close relation to the most recent common ancestors of the M. tuberculosis 
complex, including “M. canettii” [26,27]. Recent genomic investigations 
[51] have pinpointed Mycobacterium decipiens, Mycobacterium lacus, 
Mycobacterium riyadhense and Mycobacterium shinjukuense as species 
intermediate between M. kansasii and the conventional M. tuberculosis 
complex, so lipid profiles of these mycobacteria could be important in 
the evolutionary studies of TB. 
To give a generally applicable reference MC profile, the average 
M. tuberculosis profile was established by the examination of five MTBC 
strains deriving from patients (Supplementary Figure 3). The 
M. tuberculosis complex 1/8508/2014 strain has been excluded from the 
calculation of the average M. tuberculosis profile establishment, as its 
profile resembled that of the M. bovis strain provided from BEI Resources 
(Fig. 3 B) and with the published M. bovis values [25]. The most 
Fig. 3. Standard HPLC-HESI-MS mycocerosate (MC) profiles for A, 
M. tuberculosis H37Rv; B, M. bovis; C, M. kansasii. MC proportions are shown 
normalised to the major component [100]. 
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well-marked difference of this strain is that C29 MC was most prominent 
(0% RSD), while C32 was only 22% (18% RSD). The C27 MC was 38% 
(3% RSD), C30 and C33 were 15% and 0.1% (23–63% RSD), respec-
tively. On the average M. tuberculosis profile, the C32 MC was the most 
prominent, while C29 and C30 MCs were present with similar 31% and 
23% of the highest MC peak, respectively; the C33 MC reached only 2% 
of C32. The relative proportions of these M. tuberculosis MCs are in 
general accord with previously published profiles [25,33]. The overall 
distribution of individual MCs from standard and clinical M. tuberculosis, 
M. bovis and M. kansasii is shown in Supplementary Figure 4. 
4.3. Profiles of mycocerosic acids from individual subjects 
The lipid profiles observed for the extracts of both rib and soft tissue 
samples from four consistent cases are shown in Fig. 5. The 
M. tuberculosis C27 MC minor component (Fig. 3) was not detected in 
any of these extracts. The results for the samples taken from the remains 
of Terézia Hausmann (#68) were positive. In the MC profile for the soft 
tissue sample (Fig. 5 B), the main C32 peak was accompanied by major 
C29, C30 and minor C33 peaks. The rib sample (Fig. 5 A) had clear main 
C32 and major C30; however, any minor C33 was indistinct and the area 
for expected C29 was obscured. The positive rib and soft tissue profiles, 
from the remains of Anna Schneller (#78) (Fig. 5 A and B), both had the 
expected main C32 and major C29 and C30, but the minor C33 was not 
so clear. Both types of samples belonging to Erzsébet Virágh (#80) 
(Fig. 5 E, F) proved to be also positive, with clear C29, C30, C32 and C33 
peaks being detected; however, the C33 peak in case of the soft tissue 
sample was overrepresented, a rather broad peak suggesting overlap 
with an unknown component (Fig. 5 F). The rib and soft tissue of László 
Beniczky (#121) (Fig. 5 G, H) exhibited clear MC peaks for C30 and C32 
mycocerosates, with little C33. The C29 signals were questionable, as 
the rib peak (Fig. 5 G) was not fully resolved, and in the soft tissue 
extract, the peak shape was atypical (Fig. 5 H). The soft tissue samples of 
Gáspár Steitel (#25) did not contain detectable MCs (Fig. 6 B), while the 
rib extracts (Fig. 6 A) showed very weak indecisive results for C30 and 
C32 MCs. Conversely, the rib extracts from Terézia Damiani (#79) 
(Fig. 6 C) were devoid of MCs, but the soft tissue samples (Fig. 6 D) 
provided barely discernible indications of C30 and C32 MCs. These 
inconclusive results cannot be regarded as a positive indication of 
tuberculosis in these mummies, but the fact that the very weak signals 
are for two of the principal MC components (C30 and C32) may be useful 
signposts. The distribution of the individual MCs in the positive mummy 
cases (Fig. 5) is summarised in Fig. 7. 
It can be concluded that when the three most presented C32, C30, 
and C29 MCs, with a principal amount of the C32 component, are found 
in archaeological samples, infection with M. tuberculosis is indicated. 
Compliance with these requirements was recorded for the rib and soft 
tissue samples from Terézia Hausmann (#68), Anna Schneller (#78), 
Erzsébet Virágh (#80) and László Beniczky (#121) (Fig. 5). However, 
the cases of Gáspár Steitel (#25) and Terézia Damiani (#79) (Fig. 6) 
cannot be recognised as positive. In most cases, C32 MC was presented at 
least in a double ratio compared to the C30 MC, except for case #68 soft 
tissue, where the C30 and C32 mycocerosates were found in almost 
equal ratios (Fig. 5 B). Only traces of C33 mycocerosic acid were 
detected from both sample types of #68, #78, and #80, as well as from 
the soft tissue sample of #121, so the diagnostic use of this biomarker is 
limited for ancient tuberculosis. However, C33 and C34 mycocerosic 
acids have established value for recognising ancient Mycobacterium 
leprae, including joint tuberculosis-leprosy cases [26]. 
4.4. Correlation of mycocerosic acid profiles with aDNA results 
The examined individuals were initially screened by Fletcher and 
colleagues [14] for the presence of the 123-bp region of the IS6110 
insertion sequence. Positive samples were investigated for silent point 
mutations of the gyrA 95 and katG 463 genes; this differentiated the 
infectious agents into three genotypes, following the work of Sreevatsan 
and colleagues [52]. The mummy of Terézia Hausmann was the subject 
of the first metagenomic determination by Chan and colleagues [18], 
followed by a more comprehensive whole genomic study by Kay and 
co-workers [15]. Correlations of lipid and DNA biomarkers are sum-
marised below for each individual mummy. 
Terézia Hausmann (#68). Positive MC profiles (Fig. 5 A, B) matched 
the result of the DNA-based analysis; traits of gyrA 95 and katG 463 
genes were found in the chest, with the silent point mutations charac-
teristic to the group 3 genotype of M. tuberculosis [14]. Metagenomic 
analysis of a left lung specimen found a multiple infection by more than 
one M. tuberculosis strain [18]. One of the M. tuberculosis strains 
belonged to sublineage 4.1.2.1, also known as the Haarlem lineage [15, 
21]. The other strain was assigned by Kay and colleagues to lineage 4.7 
sublineage [15], a sublineage, which is currently part of sublineage 4.10 
[21]. 
Anna Schneller (#78). Amplification of the katG 463 codon from a 
rib sample by Fletcher and colleagues [14] gave good support to the 
Fig. 4. Optimisation of the HESI ion source 
and the S-lens. 1, Basic HESI ion source 
settings: 300 ◦C capillary and 300 ◦C auxil-
iary gas. 2, HESI ion source: 350 ◦C capillary 
and 300 ◦C auxiliary gas. 3, HESI ion source: 
300 ◦C capillary and 350 ◦C auxiliary gas. 4, 
HESI ion source: 350 ◦C capillary and 350 ◦C 
auxiliary gas. 5, APCI ion source: 250 ◦C 
capillary. 6, APCI ion source: 350 ◦C capil-
lary. 7, APCI ion source: 400 ◦C capillary. 8, 
HESI ion source: 350 ◦C capillary and 350 ◦C 
auxiliary gas, 70 V for S-lens. 9, HESI ion 
source: 350 ◦C capillary and 350 ◦C auxiliary 
gas, 80 V of S-lens.   
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positive MC profiles (Fig. 5C, D). Based on its sequence, the infectious 
agent could belong to the group 2 or group 3 genotype. Additional 
phylogenetic analysis revealed that the M. tuberculosis strain also 
belonged to the current MTBC sublineage 4.10 [15,21]. 
Erzsébet Virágh (#80). Similarly, Fletcher and colleagues [14] found 
that, based on the silent point mutations of gyrA 95 and katG 463 genes, 
the infectious agent belongs to the group 3 genotype. The full genomic 
examinations by Kay and colleagues [15] revealed that the 
M. tuberculosis strain belongs to the 4.1.2.1 sublineage. All this evidence 
backs the positive coherent MC profiles (Fig. 5 E, F). 
László Beniczky (#121). The MC profiles had slightly decreased 
positivity due to questionable C29 peaks (Fig. 5 G, H), but diagnostic 
PCR products have been amplified earlier from a pleura sample, with a 
silent point mutation pattern belonging to group 3 [14]. Positive 
sequencing data of a rib sample showed a mixed infection of 
M. tuberculosis sublineage 4.3 (also known as LAM) and two strains of the 
current sublineage 4.10 [15,21]. The sublineage 4.3 (also known as 
LAM) of M. tuberculosis is globally distributed, with high frequency [21]. 
Gáspár Steitel (#25). Unfortunately, the MC profiles were essentially 
negative (Fig. 6 A, B) in contrast with the previous detection of 
M. tuberculosis complex DNA [14,15]. The first PCR based aDNA ex-
aminations, using a sample taken from the left chest, detected only the 
traits of katG 463 gene, with the silent point mutation suggesting that 
the infectious agent belonged to group 2 or 3 [14]. The later meta-
genomic examinations of tissue from the abdomen region determined 
that the M. tuberculosis strain belongs to lineage 4 [15]. 
Terézia Damiani (#79). In this case, the monitored MC biomarkers 
could not be detected (Fig. 6C, D). However, Fletcher and colleagues 
Fig. 5. Positive HPLC-HESI-MS mycocerosate (MC) profiles from mummy samples #68, #78, #80, #121. Rib (R) and Soft Tissue (ST) samples from: A and B, #68 - 
Terézia Hausmann; C and D, #78 - Anna Schneller; E and F, #80 - Erzsébet Virágh; G and H, #121 - László Beniczky. MC distributions are shown normalised to the 
major component [100]. 
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[14] amplified the fragment of the katG 463 gene in the sample taken 
from the pelvis region of this individual and found the silent point 
mutation characteristic of group 2 and 3. Metagenomic analyses have 
not been performed on extracts of this mummy. 
Overall, in four of the six mummies studied, there is good correlation 
of mycocerosate profiles (Fig. 5) with positive ancient DNA analyses. In 
the two cases lacking significant mycocerosate presence (Fig. 6), but 
with good indications of aDNA biomarkers, the discrepancy may be due 
to differences in the samples investigated. Mummified individuals pro-
vide a much greater choice of areas for sampling than in skeletons 
without soft tissue. Even though the cases of Gáspár Steitel and Terézia 
Damiani (Fig. 6) were deemed negative, the very weak signals observed 
in Fig. 6 A, D could be sufficient to encourage investigation of a wider 
range of samples from these mummies. 
5. Conclusions 
The diagnosis of ancient mycobacterial disease in archaeological 
material requires a multidisciplinary approach. Suspicions of leprosy 
and tuberculosis can be aroused in skeletal material by the manifesta-
tions of characteristic bone lesions and deformities. An array of specific 
biomarkers can be brought into play to confirm initial skeletal diagnoses 
and search in the soft tissue of suspected cases [26]. The pioneering 
application of whole-genome sequencing [18] has opened the prospect 
Fig. 6. Negative HPLC-HESI-MS mycocerosate (MC) profiles from mummy samples #25, #79. Rib (R) and Soft Tissue (ST) samples from: A and B, #25 - Gáspár 
Steitel; C and D, #79 - Terézia Damiani. 
Fig. 7. The normalised distribution of positive mycocerosate profiles from mummy rib (R) and soft tissue (ST) samples. #68 – Terézia Hausmann. #78 – Anna 
Schneller. #80 – Erzsébet Virágh. #121 – László Beniczky. Also shown are a “Mummy average” and an “MTB average”, excluding anomalous MTBC-1/8508/2014. 
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of obtaining comprehensive information regarding the nature and 
number of infecting M. tuberculosis strains [15,53]. However, for over a 
quarter of a century, amplification and study of key fragments of ancient 
DNA have been successful, including the mummies in the present study 
[14]. Confidence in aDNA diagnoses has been greatly reinforced by 
recording profiles of specific lipid biomarkers, which are particularly 
robust and accessible [26]. Initial lipid targets were the C70 to C90 
mycolic acids [22–24], but the range was broadened to include the 
multimethyl-branched mycocerosic and mycolipenic acids [2,25] and 
phthiocerols [2]. 
A variety of analytical methods have been employed for mycobac-
terial lipid biomarker profiling [26]. Fluorescence HPLC is 
well-developed for the analysis of mycolic acids and phthiocerols [2,26]. 
In a single study, on a Neolithic lesioned vertebra, HPLC-MS/MS with 
electrospray ionisation (ESI) yielded profiles of individual α-, methoxy- 
and ketomycolates characteristic of M. tuberculosis [35]. Mass spec-
trometry, however, has been the basis of the analysis of ancient myco-
cerosic acids, using selected ion monitoring, negative ion-chemical 
ionisation GC-MS of pentafluorobenzyl ester derivatives [2,25,26]. This 
is a well-proven procedure, but the popularity and availability of the 
necessary instrumentation have declined over the past two decades. 
Conversely, HPLC-MS facilities have become routine in biological and 
other analytical laboratories and, in this study, an effective procedure 
has been developed. The optimised method provides an easy and quick 
way to confirm TB-infected cases among archaeological human remains. 
In the case of four mummified individuals, profiles of characteristic 
M. tuberculosis MCs were recorded (Fig. 5), but two other mummies did 
not yield diagnostic MC profiles (Fig. 6). All the mummy samples had 
been found, previously, to be positive by aDNA examination, but the 
samples in this study were not identical with those used previously and 
the sampling site may affect the results. An extended study of confirmed 
cases, with multiple sampling sites of skeletal material and soft tissue, 
where available, is suggested to clarify the situation. The present results, 
however, provide further confirmation of widespread tuberculosis in the 
Vác mummies. 
The HPLC-HESI-MS method, developed in this study, opens up a new 
avenue for the detection of ancient mycobacterial disease, encompassing 
both tuberculosis and leprosy and joint cases. Currently, the instru-
mentation required is available in many laboratories and technical de-
velopments are likely to reduce complexity and increase sensitivity and 
affordability. A particular advantage is that no chemical derivatisation 
of the particular lipid biomarkers is needed, the free acids being utilised. 
The method could be extended to include the related M. tuberculosis lipid 
biomarker, mycolipenic acid [26], and a comprehensive protocol could 
be developed to add profiles of free mycolic acids [26,35]. As noted 
above, free mycolic acids were successfully profiled in a Neolithic 
tuberculosis case [35] and this study demonstrates the powerful diag-
nostic capability of direct mass spectrometry. In the well-established 
fluorescence HPLC procedure, the recognition of diagnostic mycolate 
profiles requires extensive derivatisation and sequential reverse and 
normal phase HPLC analyses [24,26]. In contrast, in a single selected ion 
monitoring HPLC run, all the diagnostic mycolic acid data are collected 
and are available for further processing. 
CRediT authorship contribution statement 
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2017;58:37–47. https://doi.org/10.20330/AnthropKozl.2017.58.37. 
[18] Chan JZ-M, Sergeant MJ, Lee OY-C, Minnikin DE, Besra GS, Pap I, Spigelman M, 
Donoghue HD, Pallen MJ. Metagenomic analysis of tuberculosis in a mummy. 
N Engl J Med 2013;369(3):289–90. https://doi.org/10.1056/nejmc1302295. 
[19] Cseplák Gy, Pap I, Szikossy I. A váci múmiákról – Antropo-medicinális 
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glycerol ether lipid fingerprints through a novel reversed phase liquid 
chromatography-mass spectrometry protocol. Org Geochem 2013;65:53–62. 
https://doi.org/10.1016/j.orggeochem.2013.09.012. 
[41] Byrdwell WC. Atmospheric pressure chemical ionization mass spectrometry for 
analysis of lipids. Lipids 2001;36(4):327–46. https://doi.org/10.1007/s11745- 
001-0725-5. 
[42] Nichols DS, Davies NW. Improved detection of polyunsaturated fatty acids as 
phenacyl esters using liquid chromatography-ion trap mass spectrometry. 
J Microbiol Methods 2002;50(2):103–13. https://doi.org/10.1016/S0167-7012 
(02)00030-1. 
[43] Willmann J, Thiele H, Leibfritz D. Combined reversed phase HPLC, mass 
spectrometry, and NMR spectroscopy for a fast separation and efficient 
identification of phosphatidylcholines. J Biomed Biotechnol 2011:385786. https:// 
doi.org/10.1155/2011/385786. 
[44] Yunker LP, Stoddard RL, McIndoe JS. Practical approaches to the ESI-MS analysis 
of catalytic reactions. J Mass Spectrom 2014;49(1):1–8. https://doi.org/10.1002/ 
jms.3303. 
[45] Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgun 
lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev 2012;31 
(1):134–78. https://doi.org/10.1002/mas.20342. 
[46] Wang C, Wang M, Han X. Applications of mass spectrometry for cellular lipid 
analysis. Mol Biosyst 2015;11:698–713. https://doi.org/10.1039/C4MB00586D. 
[47] Koivusalo M, Haimi P, Heikinheimo L, Kostiainen R, Somerharju P. Quantitative 
determination of phospholipid compositions by ESI-MS: effects of acyl chain 
length, unsaturation, and lipid concentration on instrument response. J Lipid Res 
2001;42(4):663–72. 
[48] Crane AM, Hua HU, Coggin AD, Gugiu BG, Lam BL, Bhattacharya SK. Mass 
spectrometric analyses of phosphatidylcholines in alkali-exposed corneal tissue. 
Invest Ophthalmol Vis Sci 2012;53(11):7122–30. https://doi.org/10.1167/ 
iovs.12-10448. 
[49] Nzoughet JK, Gallart-Ayala H, Biancotto G, Henning K, Dervilly-Pinel G, Le 
Bizec B. Hydrophilic interaction (HILIC) and reverse phase liquid chromatography 
(RPLC)–high resolution MS for characterizing lipids profile disruption in serum of 
anabolic implanted bovines. Metabolomics 2015;11:1884–95. https://doi.org/ 
10.1007/s11306-015-0847-y. 
[50] Dang NA, Kuijper S, Walters E, Claassens M, van Soolingen D, Vivi-Truyols G, 
Janssen HG, Kolk AHJ. Validation of biomarkers for distinguishing Mycobacterium 
tuberculosis from non-tuberculous mycobacteria using gas chromatography–mass 
spectrometry and Chemometrics. PloS One 2013;8(10):e76263. https://doi.org/ 
10.1371/journal.pone.0076263. 
[51] Sapriel G, Brosch R. Shared pathogenomic patterns characterize a new phylotype, 
revealing transition toward host-adaptation long before speciation of 
Mycobacterium tuberculosis. Genome Biol Evol 2019;11:2420–38. https://doi.org/ 
10.1093/gbe/evz162. 8. 
[52] Sreevatsan S, Pan X, Stockbauer KE, Conell ND, Kreiswirth BN, Whittam TS, 
Musser JM. Restricted structural gene polymorphism in the Mycobacterium 
tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl 
Acad Sci USA 1997;94(18):9869–74. https://doi.org/10.1073/pnas.94.18.9869. 
[53] Bos K, Harkins K, Herbig A, Coscolla M, Weber N, Comas I, Forrest SA, Bryant JM, 
Harris SR, Schuenemann VJ, Campbell TJ, Majander K, Wilbur AK, Guichon RA, 
Steadman DLW, Krause J. Pre-Columbian mycobacterial genomes reveal seals as a 
source of New World human tuberculosis. Nature 2014;514:494–7. https://doi. 
org/10.1038/nature13591. 
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